CG MedTech Co.,Ltd. (KOSDAQ:056090)

Market Cap	238.01B +118.7%
Revenue (ttm)	45.59B +28.8%
Net Income	3.85B
EPS	32.60
Shares Out	103.26M
PE Ratio	70.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,476,449
Average Volume	3,869,214
Open	1,909.00
Previous Close	n/a
Day's Range	1,909.00 - 2,200.00
52-Week Range	830.00 - 2,200.00
Beta	-0.42
RSI	74.35
Earnings Date	n/a

About CG MedTech

CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cervical cages for cervical interbody fusion; and Velofix PEEK cage; and NeoIC PEEK cage, devices used with autograft or bone graft substitutes, as well as...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1993
• Employees: 120
• Stock Exchange: KOSDAQ
• Ticker Symbol: 056090

Financial Performance

In 2024, CG MedTech's revenue was 34.62 billion, a decrease of -0.99% compared to the previous year's 34.97 billion. Earnings were 59.69 million, a decrease of -96.34%.